diabetestalk.net

Statins DOUBLES Risk Of Diabetes, Concludes 10-year Study Into Controversial Drug

Statins DOUBLES risk of diabetes, concludes 10-year study into controversial drug

Statins DOUBLES risk of diabetes, concludes 10-year study into controversial drug

The research, published in a leading journal examined 25,970 patients over ten years and discovered statin users had a higher incidence of diabetes and also weight gain.
Patients using the drugs also had more than double the risk of diabetic complications including eye, nerve and kidney damage.
Scientists say the new research published in the leading Journal of General Internal Medicine, confirms a long suspected link between statin use and diabetes.
Professor Ishak Mansi a heart specialist at the University of Texas who led the study said: “Our findings are alarming.”
The research, will add to the debate surrounding the drugs, which are routinely given to up to 12 million patients in the UK, or around one in four adults.
Supporters say they save lives by lowering cholesterol and UK health regulators say they are safe. However increasing research has suggested the risks such as severe muscle pain, depression, fatigue, impaired memory, and stroke, may outweigh the benefits in many patients.
Many leading doctors and academics believe drug regulators over depend on studies funded by the pharmaceutical industry, details of which are kept “hidden” due to commercial confidentiality agreements.
Professor Ishak added: “There is not enough funding to carry out studies to assess these long term effects that are not funded by drug companies and therefore clouded by conflicts of interest.”
And he said drugs may be doing more harm than good for people at low risk of heart disease: “I am sceptical about the prescribing guidelines for people at lower risk (of heart disease). Continue reading

Rate this article
Total 1 ratings
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value

Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value

Merck’s Januvia (sitagliptin) and its metformin combination, Janumet, are important drugs for type 2 diabetes patients as well as for Merck’s bottom line. These drugs, which are DPP-4 inhibitors, account for more than $6 billion in sales for this drug giant. Given the growing incidence of obesity and type 2 diabetes in the world, this franchise is poised for continued growth.
However, Merck has competition in this field with a number of other drug companies, a notable one being Eli Lilly. Lilly has a variety of products for diabetics, including Jardiance (empagliflozin), a drug that acts by blocking SGLT2. (Lilly co-developed Jardiance with Boehringer Ingelheim.) Both Januvia and Jardiance lower high blood sugar, the cause of the downstream consequences of diabetes such as heart disease, kidney failure, blindness and amputations. However, just because a drug lowers blood sugar doesn’t ensure that it will reduce the ultimate complications of diabetes. Nevertheless, over the years diabetes drugs have been approved on the basis of blood sugar lowering alone.
However, last December, Lilly raised the bar for oral diabetes drugs with the acceptance by the FDA of its data showing that Jardiance not only lowered blood sugar but, in doing so, also reduced cardiovascular events in diabetic patients with heart disease. These data were generated in a trial known as the EMPA-REG OUTCOME trial. Last December, the FDA effectively blessed this work and allowed Lilly to add the cardiovascular outcome benefit to the Jardiance label. This was a big advantage to Lilly because its sales r Continue reading

The Uniquely Dangerous Eating Disorder Symptom in Type 1 Diabetes

The Uniquely Dangerous Eating Disorder Symptom in Type 1 Diabetes

Eating disorders in type 1 diabetes (T1DM) are rarely understood or recognized outside the T1DM patient and medical community. In fact, there is still a lack of awareness even inside of the world of T1DM. Despite this reality, girls and women with T1DM are close to 2.5 times more likely to develop eating disorders than those who do not have diabetes. This is a serious women’s health problem in diabetes, and it is associated with severe medical consequences.
Eating disorders in T1DM often involve a uniquely dangerous symptom – namely insulin restriction as a means of calorie purging. It is important to note that not all people with T1DM and eating disorders restrict insulin; however, the large majority of research in this area has focused on this particular eating disorder symptom. The media and lay public use the term “Diabulimia,” when referring to an eating disorder involving insulin restriction. When insulin doses are skipped or under-dosed, blood glucose levels rise, and the body attempts to excrete that glucose in the urine and thereby loses or purges calories.
Insulin restriction can lead to rapid and dramatic weight loss but also increases the risk of both acute and long-term T1DM complications and even an increased risk of death. We do not yet definitively know if there are identifiable factors that increase eating disorder risk at diabetes diagnosis or throughout the duration of T1DM. Most importantly, even less is understood about effective treatments for eating disorders in the context of T1DM.
Treatment guidelines have been created based on expert clinic Continue reading

Parenting Your Teen with Type 1 Diabetes

Parenting Your Teen with Type 1 Diabetes

By Nicole Kofman and Ashley Dartnell
Twitter summary: Teenagers + type 1 diabetes = a challenge! Tips from #CWDFFL15 & a parent
For most families, “‘adolescence is second only to infancy’ in terms of the upheaval it generates” within a household. Add managing type 1 diabetes into the mix, and things can get complicated. For parents, it can be daunting to balance giving teens space to grow and monitoring a 24/7 condition as dangerous as type 1 diabetes.
At CWD’s Friends For Life conference in July, Dr. Jill Weissberg-Benchell and CDEs Natalie Bellini and Marissa Town led a workshop called “Parenting Your Teen with Type 1.” There, they elicited an impressive list of diabetes-specific concerns that parents have regarding their teens, including but not limited to:
How can they have the peace of mind of knowing their child is reasonably within range without being a helicopter parent?
What will happen when their teen begins to drive and could have a low?
How do growth hormones interact with insulin and affect blood sugar?
How will alcohol affect diabetes management?
What additional steps do people with type 1 diabetes need to take to be prepared for college entrance exams?
All that – on top of keeping up with schoolwork and extracurricular activities! We learned some great tips from the experts and parents at this workshop. Plus, we sat down with Ashley Dartnell, a parent of one of diaTribe’s summer associates who has type 1 diabetes, to learn more about her personal experience parenting a teen with type 1 and to gain a unique perspective outside of what we lear Continue reading

The fast answer to beating type 2 diabetes

The fast answer to beating type 2 diabetes

More than 29 million people in the U.S. have diabetes and another 86 million adults (more than one in three) are pre-diabetic.
And according to the CDC, 15 to 30 percent of those people with prediabetes will develop type 2 diabetes within five years without major lifestyle changes.
Even worse, the percentage of people developing diabetes has continued to rise year over year for the last 50 years thanks to our increasingly sedentary lifestyles and the low-fat food trend that upped the amount of blood sugar-elevating carbs in the American diet.
If you are one of the more than 100 million Americans who either suffers from diabetes or has blood sugar problems, changing your diet the best place to start.
Eating more vegetables, fiber and fish are all parts of the “Diabetes Diet” as well as avoiding sugar and processed foods.
While those are all good things, there is a simple dietary trick that most doctors completely neglect in helping patients avoid Type 2 diabetes…
Fasting and your blood sugar
Fasting is reducing or completely eliminating the consumption of food or drink for a certain amount of time.
Studies have shown fasting may improve pancreatic function, improve your insulin levels and your insulin sensitivity, enhance metabolism and weight loss, improve body composition and prevent and even reverse type 2 diabetes.
There are a number of ways to achieve the blood sugar control benefits delivered by fasting and you can choose the method that works best for you…
#1 – Alternating days
In this model of intermittent fasting, you alternate days of normal calorie consu Continue reading

No more pages to load

Popular Articles

  • Type 2 Diabetes, Statins And Their Relationship To The Thyroid

    Connecting The Dots My journey started long before I ever knew anything about thyroid disease. At twenty-five years old, I found out my father had his first heart attack and that he also had type 2 diabetes. That side of the family had a predisposition to being overweight and not living a healthy lifestyle. This scared me so much that I took drastic measures. In 1989, I changed everything about my ...

  • Do Statins Raise Odds for Type 2 Diabetes?

    TUESDAY, Oct. 24, 2017 (HealthDay News) -- Cholesterol-lowering medications known as statins may lower your risk of heart disease, but also might boost the odds you'll develop type 2 diabetes, new research suggests. "In a group of people at high risk of type 2 diabetes, statins do seem to increase the risk of developing diabetes by about 30 percent," said the study's lead author, Dr. Jill Crandall ...

  • More Evidence of Link Between Statins and Diabetes

    The use of statin drugs has already been associated with over 300 adverse health effects, and now, a new study has found that long-term statin use may increase the risk of type 2 diabetes by 30 percent in high-risk individuals. The discovery is the latest in the body of research that raises doubt about the safety of the popular cholesterol drugs. In the new study, scientists at the Albert Einstein ...

  • ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes

    Among adolescents with type 1 diabetes, rapid increases in albumin excretion during puberty precede the development of microalbuminuria and macroalbuminuria, long-term risk factors for renal and cardiovascular disease. We hypothesized that adolescents with high levels of albumin excretion might benefit from angiotensin-converting–enzyme (ACE) inhibitors and statins, drugs that have not been full ...

  • Statins Related to Diabetes Progression for Obese Patients

    Statin therapy may be elevating risk of type 2 diabetes in high-risk adults. Statins or HMG-CoA reductase inhibitors provide several cardiovascular benefits in addition to lowering cholesterol. This could lead individuals to believe that statins may potentially aid in reducing diabetes risk. However, in numerous cardiovascular disease (CV) prevention studies, it has been consistently found that ...

  • Rigorous diet can put Type 2 diabetes into remission, study finds

    Some people with Type 2 diabetes were able to put the disease in remission without medication by following a rigorous diet plan, according to a study published today in the Lancet medical journal. "Our findings suggest that even if you have had Type 2 diabetes for six years, putting the disease into remission is feasible," Michael Lean, a professor from the University of Glasgow in Scotland who co ...

  • Studies That Really Trash Statins Overlooked by Most Doctors and the FDA

    In the past, some MDs have proposed that statin drugs should be put into our water supplies and handed out to fast food customers. As if fluoridated water posing as a necessary mass medicine that turns out to be toxic isn’t enough. One out of four Americans aged 55 or over are on a statin drug, most of whom are without cardiovascular and heart problems. Many are prescribed statins solely for hig ...

  • Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study

    OBJECTIVE We assessed the prevalence of and risk factors for diabetic peripheral neuropathy (DPN) in youth with type 1 diabetes (T1D) and type 2 diabetes (T2D) enrolled in the SEARCH for Diabetes in Youth (SEARCH) study. RESEARCH DESIGN AND METHODS The Michigan Neuropathy Screening Instrument (MNSI) was used to assess DPN in 1,734 youth with T1D (mean ± SD age 18 ± 4 years, T1D duration 7.2 ± 1 ...

  • Diabetes drug and aspirin boosts cancer drug effectiveness | Daily Mail Online

    Metformin may slow breast cancer growth and reverse treatment resistance Adding aspirin to a cancer drug could help combat tumors resistant to therapies These include pancreatic, lung and colorectal cancers, as well as melanomas A widely-used diabetes drug and over-the-counter aspirin could help boost the effectiveness of cancer treatments, two studies suggest. Research has found that metfor ...

Related Articles